Latest Security News

Monadelphous Group Limited has secured approximately $110 million in new contracts spanning resources, energy, and renewable sectors, reinforcing its foothold across Australia and Papua New Guinea.

BlueScope Steel’s board has unanimously dismissed a $30 per share takeover proposal from SGH and Steel Dynamics, calling it opportunistic and undervaluing the company’s assets and growth prospects.

BlackRock Investment Management (Australia) Limited has announced the final cash distributions for over 30 Australian domiciled iShares ETFs listed on the ASX and CBOE Australia, detailing payment schedules and reinvestment options.

Hydrix Limited’s subsidiary has landed a significant A$2.5 million contract to develop SynCardia’s next-generation fully implantable Total Artificial Heart, marking a major step in advanced cardiovascular technology.

Augustus Minerals has addressed ASX concerns over its recent appointment and election of a new director, clarifying compliance with listing rules despite timing challenges.

Magnetite Mines Limited has been granted a new exploration licence adjacent to its Ironback Hill rare earth element project, expanding its strategic footprint in South Australia’s Braemar Iron Region. The licence offers promising optionality for future rare earth exploration while the company maintains focus on its core iron ore development.

CurveBeam AI has received official Chinese regulatory approval for a strategic $10 million investment from WEGO Orthopaedics, marking a major step in its expansion into Greater China. The initial $4 million tranche at a premium share price is expected imminently, underpinning a decade-long commercialisation deal.

UC San Diego Health has begun clinical use of 4DMedical’s CT – VQ™, marking the fourth leading US academic medical centre to adopt this innovative lung imaging technology since FDA clearance. This milestone underscores 4DMedical’s rapid commercial traction and growing influence in respiratory diagnostics.

Island Pharmaceuticals has been granted a key US patent for Galidesivir, extending intellectual property protection through 2031 for treating filoviridae viruses including Marburg and Ebola. This milestone aligns with the company’s clinical development strategy and recent FDA regulatory progress.

SQX Resources’ subsidiary AM6 has secured final drilling permits for its Red Bird Gold Project in Arizona, enabling the start of a maiden 2,500m Reverse Circulation drilling program targeting high-grade gold mineralisation and extensions.

Siren Gold Limited has reported exceptional first assay results from its Queen Charlotte Antimony-Gold Project in New Zealand, revealing multiple high-grade gold and antimony intersections. These findings set the stage for a maiden drilling program in 2026, highlighting the project's strategic importance in critical minerals.

SQX Resources has completed its acquisition of an 80% interest in AM6 Pty Ltd, gaining control of two promising gold and silver projects in Montana and Arizona. The move is bolstered by recent high-grade sampling results and the appointment of a seasoned executive director.